Question 1

What is Revolution Medicines?

Accepted Answer

Revolution Medicines is a Company.

Question 2

How often does Revolution Medicines appear in global news?

Accepted Answer

Tracked across 8 news events drawn from 353 articles.

Question 3

When was Revolution Medicines first tracked by NewsDesk?

Accepted Answer

First tracked on Apr 15, 2026.

Question 4

When was Revolution Medicines last mentioned in news?

Accepted Answer

Last active on Jun 12, 2026.

Question 5

What is Revolution Medicines's current news sentiment?

Accepted Answer

Aggregate sentiment score: 29 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Revolution Medicines in global news coverage?

Accepted Answer

Attention score of 7, derived from article volume and coverage intensity across 8 events.

Question 7

What is the most recent event involving Revolution Medicines?

Accepted Answer

Revolution_Medicines' daraxonrasib extends pancreatic cancer survival (May 29, 2026, 74 articles).

Question 8

Who is Revolution Medicines most connected to?

Accepted Answer

Top relationships: Erasca, Erasca, United States — Food and Drug Administration.

Question 9

How did the "Revolution_Medicines' daraxonrasib extends pancreatic cancer survival" event impact Revolution Medicines?

Accepted Answer

Revolution Medicines developed daraxonrasib, the experimental drug that has shown significant promise in treating advanced pancreatic cancer, leading to increased attention and potential for market growth for the company.

Question 10

How did the "Erasca faces class action lawsuit" event impact Revolution Medicines?

Accepted Answer

Revolution Medicines (RevMed) is the company that alleged Erasca's ERAS-0015 infringes on its patent and involves trade secret misappropriation, initiating the legal dispute.

Question 11

How did the "Erasca faces class action lawsuit" event impact Revolution Medicines?

Accepted Answer

Revolution Medicines>>> alleged that Erasca>>>'s ERAS-0015 infringes on its patent and involves trade secret misappropriation, which triggered the class action lawsuit against Erasca>>>.

Question 12

How did the "Erasca faces class action lawsuit" event impact Revolution Medicines?

Accepted Answer

Revolution Medicines (RevMed) alleged that Erasca's ERAS-0015 infringes on its patent and involves trade secret misappropriation, and that Erasca improperly compared preclinical data of their respective drug candidates.

Question 13

How did the "Targeted Cancer Drugs Boost Survival" event impact Revolution Medicines?

Accepted Answer

Revolution Medicines>>> is developing daraxonrasib, a new drug targeting the RAS gene, which offers hope for patients to overcome resistance to standard treatments.

Question 14

How did the "Erasca securities fraud class action" event impact Revolution Medicines?

Accepted Answer

Revolution Medicines is mentioned as a competitor to Erasca, with its drug candidate RMC-6236 being used for comparison in Erasca's allegedly misleading statements. This event has a neutral to slightly positive impact on Revolution Medicines.

Question 15

How did the "Global Geopolitical, Economic, and Tech Updates" event impact Revolution Medicines?

Accepted Answer

Revolution Medicines is the maker of daraxonrasib, an experimental pill showing promise for advanced pancreatic cancer, and plans to seek United States — Food and Drug Administration approval.

Question 16

How is this data collected?

Accepted Answer

NewsDesk aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.